Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 21:15:213-239.
doi: 10.2147/CLEP.S392416. eCollection 2023.

A Review of Major Danish Biobanks: Advantages and Possibilities of Health Research in Denmark

Kristina Laugesen  1 , Jonas Mengel-From  2   3 , Kaare Christensen  2   3   4 , Jørn Olsen  1 , David M Hougaard  5   6 , Lasse Boding  7 , Anja Olsen  8   9 , Christian Erikstrup  10 , Merete Lund Hetland  11   12 , Estrid Høgdall  12   13 , Alisa D Kjaergaard  14 , Erik Sørensen  15 , Anja Brügmann  16 , Eva Rabing Brix Petersen  17 , Ivan Brandslund  17   18 , Børge G Nordestgaard  19 , Gorm B Jensen  20 , Nils Skajaa  1 , Frederikke Schønfeldt Troelsen  1 , Cecilia Hvitfeldt Fuglsang  1 , Lise Skovgaard Svingel  1 , Henrik T Sørensen  1
Affiliations
Review

A Review of Major Danish Biobanks: Advantages and Possibilities of Health Research in Denmark

Kristina Laugesen et al. Clin Epidemiol. .

Abstract

Biobank research may lead to an improved understanding of disease etiology and advance personalized medicine. Denmark (population ~5.9 million) provides a unique setting for population-based health research. The country is a rich source of biobanks and the universal, tax-funded healthcare system delivers routinely collected data to numerous registries and databases. By virtue of the civil registration number (assigned uniquely to all Danish citizens), biological specimens stored in biobanks can be combined with clinical and demographic data from these population-based health registries and databases. In this review, we aim to provide an understanding of advantages and possibilities of biobank research in Denmark. As knowledge about the Danish setting is needed to grasp the full potential, we first introduce the Danish healthcare system, the Civil Registration System, the population-based registries, and the interface with biobanks. We then describe the biobank infrastructures, comprising the Danish National Biobank Initiative, the Bio- and Genome Bank Denmark, and the Danish National Genome Center. Further, we briefly provide an overview of fourteen selected biobanks, including: The Danish Newborn Screening Biobank; The Danish National Birth Cohort; The Danish Twin Registry Biobank; Diet, Cancer and Health; Diet, Cancer and Health - Next generations; Danish Centre for Strategic Research in Type 2 Diabetes; Vejle Diabetes Biobank; The Copenhagen Hospital Biobank; The Copenhagen City Heart Study; The Copenhagen General Population Study; The Danish Cancer Biobank; The Danish Rheumatological Biobank; The Danish Blood Donor Study; and The Danish Pathology Databank. Last, we inform on practical aspects, such as data access, and discuss future implications.

Keywords: biobank; epidemiology; healthcare system; precision medicine; registries; research.

PubMed Disclaimer

Conflict of interest statement

MLH reports grants from AbbVie, Biogen, BMS, Celltrion, Eli Lilly, Janssen Biologics B.V., Lundbeck Foundation, MSD, Pfizer, Roche, Samsung Bioepis, Sandoz, Novartis; also reports payment/honoraria for lectures, presentations or similar. No personal income but paid to institution from Pfizer, Medac, and Sandoz; participation in a Data Safety Monitoring Board or Advisory Board. No personal income but paid to institution from AbbVie, outside the submitted work. MLH also has chaired the steering committee of the Danish Rheumatology Quality Registry (DANBIO, DRQ), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH co-chairs EuroSpA, which generates real-world evidence of treatment of psoriatic arthritis and axial spondyloarthritis based on secondary data and is partly funded by Novartis. LSS reports The Department Clinical Epidemiology is involved in studies with funding from various companies as research grants to and administered by Aarhus University. None of these studies are related to the current study. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Danish biobanks can be linked to hundreds of population-based registries and databases by the civil registration number.
Figure 2
Figure 2
Organization of the Bio- and Genome Bank Denmark.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Frank L. Epidemiology. The epidemiologist’s dream: Denmark. Science. 2003;301(5630):163. doi:10.1126/science.301.5630.163 - DOI - PubMed
    1. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398–2399. doi:10.1126/science.287.5462.2398 - DOI - PubMed
    1. Demenais F, Margaritte-Jeannin P, Barnes KC, et al. Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat Genet. 2018;50(1):42–53. doi:10.1038/s41588-017-0014-7 - DOI - PMC - PubMed
    1. Day FR, Thompson DJ, Helgason H, et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017;49(6):834–841. doi:10.1038/ng.3841 - DOI - PMC - PubMed
    1. Barban N, Jansen R, de Vlaming R, et al. Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Nat Genet. 2016;48(12):1462–1472. doi:10.1038/ng.3698 - DOI - PMC - PubMed